Sign Up Today and Learn More About Colossal Biosciences Stock
Invest in or calculate the value of your shares in Colossal Biosciences or other pre-IPO companies through EquityZen's platform.
Colossal Biosciences Stock
Colossal is a bioscience and genetic engineering company focused on de-extinction of past species.
About Colossal Biosciences Stock
Founded
2021
Headquarters
Dallas, TX, US
Industries
Colossal Biosciences Press Mentions
Stay in the know about the latest news on Colossal Biosciences
De-extinction of the woolly mammoth takes a major step forwards: Scientists reconstruct the chromosomes of a 52,000-year-old creature - and it could allow them to resurrect the lost species
dailymail • Jul 15, 2024
Colossal Announces New Indigenous Partnerships and Forms Indigenous Council to Prioritize the Conservation, De-Extinction, Rewilding and Rematriation Issues that Matter to Tribal Communities in the US
businesswire • Jul 12, 2024
5 Interesting Startup Deals You May Have Missed In April: Firefighting Robots And Animal-Free Eggs
news • May 03, 2024
Colossal's Woolly Mammoth Project Advances as Elephant iPSCs Clear Milestones
genengnews • Apr 26, 2024
Colossal Announces $7.5M in New Investments in Ancient DNA Academic Research
dallasinnovates • Apr 26, 2024
Colossal Biosciences Management
Leadership team at Colossal Biosciences
Founder & CEO
Ben Lamm
Co-Founder & Chief Business Officer
Peter Phillips
Join now and verify your accreditation status to gain access to:
- Colossal Biosciences current valuation
- Colossal Biosciences stock price
- Available deals in Colossal Biosciences and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Colossal Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Colossal Biosciences through EquityZen funds. These investments are made available by existing Colossal Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Colossal Biosciences stock?
Shareholders can sell their Colossal Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
